JPRN-jRCT2080224917已完成3 期
A Phase 3, Multicenter, Randomized, Double-Blind Noninferiority Study of Oral Solithromycin Compared to Oral Azithromycin in the Treatment of Patients with Community-Acquired Pneumonia
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 506
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Age: 18 years or older (at the time of obtaining informed consent)
- •2. Sex : Irrespective
- •3. Outpatient/hospitalization: Irrespective
- •4. Patients with no history of hospitalization within 2 weeks before the development of pneumonia, or no history of hospitalization in a long-term care institution
- •5. Patients with newly developed infiltrative shadow on either chest X-ray imaging or computed tomography (CT) imaging taken within 48 hours before the start of study drug administration
- •6. Patients from whom written informed consent can be obtained from the patients themselves
排除标准
- •1. Patients with symptoms which are showing improvement by having received systemic oral antibacterial drugs
- •2. Patients with a history of allergy to macrolides or ketolides
研究者
相似试验
进行中（未招募）
1 期
A Study to Investigate ABP 654 for the Treatment of Subjects with Moderate to Severe Plaque PsoriasisEUCTR2020-003184-25-LTAmgen, Inc.542
进行中（未招募）
1 期
A Study to Investigate ABP 654 for the Treatment of Subjects with Moderate to Severe Plaque PsoriasisEUCTR2020-003184-25-BGAmgen, Inc.542
进行中（未招募）
1 期
A Study to Investigate ABP 654 for the Treatment of Subjects with Moderate to Severe Plaque PsoriasisModerate to Severe Plaque PsoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858EUCTR2020-003184-25-EEAmgen, Inc.542
进行中（未招募）
1 期
A Study to Investigate ABP 654 for the Treatment of Subjects with Moderate to Severe Plaque PsoriasisEUCTR2020-003184-25-HUAmgen, Inc.542
进行中（未招募）
1 期
A Study to Investigate ABP 654 for the Treatment of Subjects with Moderate to Severe Plaque PsoriasisModerate to Severe Plaque PsoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858EUCTR2020-003184-25-LVAmgen, Inc.542